Evidence map›Paper›PMID 38476368›Full record

ArticleFrontiers in oncology2024

Corrigendum: Sequential PET/CT and pathological biomarker crosstalk predict response to PD-1 blockers alone or combined with sunitinib in propensity score-matched cohorts of cancer of unknown primary treatment.

Youlong Wang, Qi Huang, Guanqing Zhong, Jun Lv, Qinzhi Guo, Yifei Ma, Xinjia Wang, Jiling Zeng

Open access · goldAbstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in oncology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 96% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 7 institutions in 1 country.

Youlong Wang *Hainan Hospital of PLA General Hospital, Department of General Surgery, Haitang District, Sanya, China.
Qi Huang *Department of Clinical Laboratory, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer Center, Guangzhou, China.
Guanqing Zhong *Department of Clinical Laboratory, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer Center, Guangzhou, China.
Jun LvDepartment of Infectious Diseases, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Qinzhi GuoPancreas Center of Guangdong Provincial People's Hospital, Guangzhou, China.
Yifei MaDepartment of Spine Surgery, The Second Affiliated Hospital, Shantou University Medical College, Shantou, China.
Xinjia WangDepartment of Spine Surgery, The Second Affiliated Hospital, Shantou University Medical College, Shantou, China.
Jiling ZengDepartment of Nuclear Medicine, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Center, Guangzhou, China.
Sun Yat-sen University Cancer Center · CNFirst Affiliated Hospital of Zhengzhou University · CNGuangdong Provincial People's Hospital · CNHainan General Hospital · CNSecond Affiliated Hospital of Shantou University Medical College · CNShantou University · CNSun Yat-sen University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

[This corrects the article DOI: 10.3389/fonc.2023.1191611.].

Indexed as

cancer of unknow primaryEFGRPET/CT (18)F-FDGsunitinbVEGFR

Identifiers

PMID38476368
PMCPMC10931807
OpenAlexW4392221562

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.